Jinming Xing, PharmD

As part of the Biomarker team within the early phase Clinical Development at Novartis, Jinming spearheaded the design and conduct of pilot study evaluating patient centric blood sampling device. Prior to joining Novartis, Jinming performed bioanalytical work on LC-MS/MS to support DMPK studies at contract research organization, and completed his PharmD at The Ohio State University.

“Becoming a father gave me brand new perspectives to the work that I do”